Title : Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.

Pub. Date : 2010 Aug

PMID : 20672450






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX. Buprenorphine COMM domain containing 3 Homo sapiens
2 BACKGROUND: This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX. Buprenorphine COMM domain containing 3 Homo sapiens